Acute 0 5 0 5 B-chronic_disease
medical 6 13 6 13 I-chronic_disease
illnesses 14 23 14 23 I-chronic_disease
precluding 24 34 24 34 O
participation 35 48 35 48 O
in 49 51 49 51 O
the 52 55 52 55 O
studies 56 63 56 63 O

Age 0 3 64 67 B-age
18 4 6 68 70 B-lower_bound
- 6 7 70 71 O
70 7 9 71 73 B-upper_bound
years 10 15 74 79 I-upper_bound

Alcohol 0 7 80 87 O
intake 8 14 88 94 O
of 15 17 95 97 O
less 18 22 98 102 O
than 23 27 103 107 O
20 28 30 108 110 B-upper_bound
g 31 32 111 112 I-upper_bound
per 33 36 113 116 O
day 37 40 117 120 O
in 41 43 121 123 O
females 44 51 124 131 B-gender
and 52 55 132 135 O
30 56 58 136 138 O
g 59 60 139 140 O
per 61 64 141 144 O
day 65 68 145 148 O
in 69 71 149 151 O
males 72 77 152 157 O

Decompensated 0 13 158 171 O
liver 14 19 172 177 B-chronic_disease
disease 20 27 178 185 I-chronic_disease
as 28 30 186 188 O
evidenced 31 40 189 198 O
by 41 43 199 201 O
clinical 44 52 202 210 O
features 53 61 211 219 O
of 62 64 220 222 O
hepatic 65 72 223 230 B-chronic_disease
failure 73 80 231 238 I-chronic_disease
( 81 82 239 240 O
variceal 82 90 240 248 B-chronic_disease
bleeding 91 99 249 257 I-chronic_disease
, 99 100 257 258 O
ascites 101 108 259 266 B-chronic_disease
, 108 109 266 267 O
hepatic 110 117 268 275 B-chronic_disease
encephalopathy 118 132 276 290 I-chronic_disease
etc 133 136 291 294 O
. 136 137 294 295 O
) 137 138 295 296 O
and 139 142 297 300 O
laboratory 143 153 301 311 O
investigations 154 168 312 326 O
( 169 170 327 328 O
prolonged 170 179 328 337 O
prothrombin 180 191 338 349 O
time 192 196 350 354 O
with 197 201 355 359 O
INR 202 205 360 363 B-clinical_variable
> 206 207 364 365 O
1.3 208 211 366 369 B-lower_bound
, 211 212 369 370 O
hypoalbuminemia 213 228 371 386 O
with 229 233 387 391 O
serum 234 239 392 397 B-clinical_variable
albumin 240 247 398 405 I-clinical_variable
less 248 252 406 410 O
than 253 257 411 415 O
3.0 258 261 416 419 B-upper_bound
g 262 263 420 421 I-upper_bound
/ 263 264 421 422 I-upper_bound
dL 264 266 422 424 I-upper_bound
, 266 267 424 425 O
direct 268 274 426 432 B-clinical_variable
bilirubin 275 284 433 442 I-clinical_variable
> 285 286 443 444 O
1.3 287 290 445 448 B-lower_bound
mg 291 293 449 451 I-lower_bound
/ 293 294 451 452 I-lower_bound
dL 294 296 452 454 I-lower_bound
, 296 297 454 455 O
or 298 300 456 458 O
presence 301 309 459 467 O
of 310 312 468 470 O
esophageal 313 323 471 481 B-chronic_disease
varices 324 331 482 489 I-chronic_disease
etc 332 335 490 493 O
. 335 336 493 494 O
) 336 337 494 495 O

Evidence 0 8 496 504 O
of 9 11 505 507 O
hepatocellular 12 26 508 522 B-cancer
carcinoma 27 36 523 532 I-cancer
: 36 37 532 533 O
alpha 38 43 534 539 B-clinical_variable
- 43 44 539 540 I-clinical_variable
fetoprotein 44 55 540 551 I-clinical_variable
levels 56 62 552 558 I-clinical_variable
greater 63 70 559 566 O
than 71 75 567 571 O
200 76 79 572 575 B-lower_bound
ng 80 82 576 578 I-lower_bound
/ 82 83 578 579 I-lower_bound
ml 83 85 579 581 I-lower_bound
and/or 86 92 582 588 O
liver 93 98 589 594 B-chronic_disease
mass 99 103 595 599 I-chronic_disease
on 104 106 600 602 O
imaging 107 114 603 610 O
study 115 120 611 616 O
suggestive 121 131 617 627 O
of 132 134 628 630 O
liver 135 140 631 636 B-cancer
cancer 141 147 637 643 I-cancer

Hematocrit 0 10 644 654 B-clinical_variable
of 11 13 655 657 O
less 14 18 658 662 O
than 19 23 663 667 O
30 24 26 668 670 B-upper_bound
% 26 27 670 671 I-upper_bound

Hepatic 0 7 672 679 B-clinical_variable
steatosis 8 17 680 689 I-clinical_variable
( 18 19 690 691 O
> 19 20 691 692 O
5.6 20 23 692 695 B-lower_bound
% 23 24 695 696 I-lower_bound
hepatic 25 32 697 704 B-clinical_variable
triglyceride 33 45 705 717 I-clinical_variable
content 46 53 718 725 O
) 53 54 725 726 O
as 55 57 727 729 O
demonstrated 58 70 730 742 O
by 71 73 743 745 O
1H 74 76 746 748 O
magnetic 77 85 749 757 B-treatment
resonance 86 95 758 767 I-treatment
spectroscopy 96 108 768 780 I-treatment

History 0 7 781 788 O
of 8 10 789 791 O
weight 11 17 792 798 O
loss 18 22 799 803 O
during 23 29 804 810 O
past 30 34 811 815 B-upper_bound
3 35 36 816 817 I-upper_bound
months 37 43 818 824 I-upper_bound

Hypersensitivity 0 16 825 841 O
or 17 19 842 844 O
intolerance 20 31 845 856 O
to 32 34 857 859 O
OCA 35 38 860 863 B-allergy_name
or 39 41 864 866 O
any 42 45 867 870 O
components 46 56 871 881 O
of 57 59 882 884 O
its 60 63 885 888 O
formulation 64 75 889 900 O

Known 0 5 901 906 O
HIV 6 9 907 910 B-chronic_disease
- 9 10 910 911 O
infected 10 18 911 919 O
patient 19 26 920 927 O

Laboratory 0 10 928 938 O
or 11 13 939 941 O
other 14 19 942 947 O
histologic 20 30 948 958 O
findings 31 39 959 967 O
highly 40 46 968 974 O
suggestive 47 57 975 985 O
of 58 60 986 988 O
liver 61 66 989 994 B-chronic_disease
disease 67 74 995 1002 I-chronic_disease
due 75 78 1003 1006 O
to 79 81 1007 1009 O
causes 82 88 1010 1016 O
other 89 94 1017 1022 O
than 95 99 1023 1027 O
non 100 103 1028 1031 B-chronic_disease
- 103 104 1031 1032 I-chronic_disease
alcoholic 104 113 1032 1041 I-chronic_disease
steatohepatitis 114 129 1042 1057 I-chronic_disease
, 129 130 1057 1058 O
such 131 135 1059 1063 O
as 136 138 1064 1066 O
chronic 139 146 1067 1074 B-chronic_disease
viral 147 152 1075 1080 I-chronic_disease
hepatitis 153 162 1081 1090 I-chronic_disease
, 162 163 1090 1091 O
autoimmune 164 174 1092 1102 B-chronic_disease
hepatitis 175 184 1103 1112 I-chronic_disease
, 184 185 1112 1113 O
primary 186 193 1114 1121 B-chronic_disease
biliary 194 201 1122 1129 I-chronic_disease
cirrhosis 202 211 1130 1139 I-chronic_disease
, 211 212 1139 1140 O
biliary 213 220 1141 1148 B-chronic_disease
obstruction 221 232 1149 1160 I-chronic_disease
or 233 235 1161 1163 O
genetic 236 243 1164 1171 O
liver 244 249 1172 1177 B-chronic_disease
diseases 250 258 1178 1186 I-chronic_disease
such 259 263 1187 1191 O
as 264 266 1192 1194 O
Wilson 267 273 1195 1201 B-chronic_disease
's 273 275 1201 1203 I-chronic_disease
disease 276 283 1204 1211 I-chronic_disease
, 283 284 1211 1212 O
hemochromatosis 285 300 1213 1228 B-chronic_disease
or 301 303 1229 1231 O
alpha-1 304 311 1232 1239 B-chronic_disease
- 311 312 1239 1240 I-chronic_disease
antitrypsin 312 323 1240 1251 I-chronic_disease
deficiency 324 334 1252 1262 I-chronic_disease

Participants 0 12 1263 1275 O
and 13 16 1276 1279 O
their 17 22 1280 1285 O
partners 23 31 1286 1294 O
with 32 36 1295 1299 O
whom 37 41 1300 1304 O
they 42 46 1305 1309 O
are 47 50 1310 1313 O
having 51 57 1314 1320 O
sex 58 61 1321 1324 O
, 61 62 1324 1325 O
must 63 67 1326 1330 O
use 68 71 1331 1334 B-contraception_consent
medically 72 81 1335 1344 I-contraception_consent
- 81 82 1344 1345 I-contraception_consent
acceptable 82 92 1345 1355 I-contraception_consent
birth 93 98 1356 1361 I-contraception_consent
control 99 106 1362 1369 I-contraception_consent
( 107 108 1370 1371 I-contraception_consent
contraceptives 108 122 1371 1385 I-contraception_consent
) 122 123 1385 1386 I-contraception_consent
during 124 130 1387 1393 O
the 131 134 1394 1397 O
study 135 140 1398 1403 O

Patients 0 8 1404 1412 O
on 9 11 1413 1415 O
bile 12 16 1416 1420 B-treatment
acid 17 21 1421 1425 I-treatment
binding 22 29 1426 1433 I-treatment
resins 30 36 1434 1440 I-treatment
, 36 37 1440 1441 O
cholestyramine 38 52 1442 1456 B-treatment
, 52 53 1456 1457 O
colestipol 54 64 1458 1468 B-treatment
or 65 67 1469 1471 O
colesevelam 68 79 1472 1483 B-treatment

Patients 0 8 1484 1492 O
with 9 13 1493 1497 O
familial 14 22 1498 1506 B-chronic_disease
partial 23 30 1507 1514 I-chronic_disease
lipodystrophy 31 44 1515 1528 I-chronic_disease
of 45 47 1529 1531 O
the 48 51 1532 1535 O
Dunnigan 52 60 1536 1544 O
variety 61 68 1545 1552 O
with 69 73 1553 1557 O
heterozygous 74 86 1558 1570 O
disease 87 94 1571 1578 O
- 94 95 1578 1579 O
causing 95 102 1579 1586 O
missense 103 111 1587 1595 O
mutation 112 120 1596 1604 O
in 121 123 1605 1607 O
lamin 124 129 1608 1613 O
A 130 131 1614 1615 O
/ 131 132 1615 1616 O
C 132 133 1616 1617 O
( 134 135 1618 1619 O
LMNA 135 139 1619 1623 O
) 139 140 1623 1624 O
gene 141 145 1625 1629 O

Pregnant 0 8 1630 1638 B-pregnancy

Previous 0 8 1639 1647 O
clinical 9 17 1648 1656 O
diagnosis 18 27 1657 1666 O
of 28 30 1667 1669 O
diabetes 31 39 1670 1678 B-chronic_disease
mellitus 40 48 1679 1687 O
or 49 51 1688 1690 O
fasting 52 59 1691 1698 B-clinical_variable
blood 60 65 1699 1704 I-clinical_variable
glucose 66 73 1705 1712 I-clinical_variable
≥ 74 75 1713 1714 O
126 76 79 1715 1718 B-lower_bound
mg 80 82 1719 1721 I-lower_bound
/ 82 83 1721 1722 I-lower_bound
dL 83 85 1722 1724 I-lower_bound
or 86 88 1725 1727 O
hemoglobin 89 99 1728 1738 B-clinical_variable
A1c 100 103 1739 1742 I-clinical_variable
≥ 104 105 1743 1744 O
6.5 106 109 1745 1748 B-lower_bound
% 109 110 1748 1749 I-lower_bound

Significant 0 11 1750 1761 O
systemic 12 20 1762 1770 O
or 21 23 1771 1773 O
major 24 29 1774 1779 O
illnesses 30 39 1780 1789 O
other 40 45 1790 1795 O
than 46 50 1796 1800 O
liver 51 56 1801 1806 B-chronic_disease
disease 57 64 1807 1814 I-chronic_disease
, 64 65 1814 1815 O
such 66 70 1816 1820 O
as 71 73 1821 1823 O
congestive 74 84 1824 1834 B-chronic_disease
heart 85 90 1835 1840 I-chronic_disease
failure 91 98 1841 1848 I-chronic_disease
, 98 99 1848 1849 O
cerebrovascular 100 115 1850 1865 B-chronic_disease
disease 116 123 1866 1873 I-chronic_disease
, 123 124 1873 1874 O
respiratory 125 136 1875 1886 B-chronic_disease
failure 137 144 1887 1894 I-chronic_disease
, 144 145 1894 1895 O
renal 146 151 1896 1901 B-chronic_disease
failure 152 159 1902 1909 I-chronic_disease
( 160 161 1910 1911 O
serum 161 166 1911 1916 B-clinical_variable
creatinine 167 177 1917 1927 I-clinical_variable
> 178 179 1928 1929 O
2 179 180 1929 1930 B-lower_bound
mg 181 183 1931 1933 I-lower_bound
/ 183 184 1933 1934 I-lower_bound
dL 184 186 1934 1936 I-lower_bound
) 186 187 1936 1937 O
, 187 188 1937 1938 O
acute 189 194 1939 1944 B-chronic_disease
pancreatitis 195 207 1945 1957 I-chronic_disease
, 207 208 1957 1958 O
organ 209 214 1959 1964 B-treatment
transplantation 215 230 1965 1980 I-treatment
, 230 231 1980 1981 O
serious 232 239 1982 1989 O
psychiatric 240 251 1990 2001 B-chronic_disease
disease 252 259 2002 2009 I-chronic_disease
, 259 260 2009 2010 O
and 261 264 2011 2014 O
malignancy 265 275 2015 2025 B-cancer
, 275 276 2025 2026 O
that 277 281 2027 2031 O
could 282 287 2032 2037 O
interfere 288 297 2038 2047 O
with 298 302 2048 2052 O
the 303 306 2053 2056 O
trial 307 312 2057 2062 O
and 313 316 2063 2066 O
adequate 317 325 2067 2075 O
follow 326 332 2076 2082 O
up 333 335 2083 2085 O

Treatment 0 9 2086 2095 B-treatment
with 10 14 2096 2100 I-treatment
drugs 15 20 2101 2106 I-treatment
associated 21 31 2107 2117 O
with 32 36 2118 2122 O
steatohepatitis 37 52 2123 2138 B-chronic_disease
, 52 53 2138 2139 O
e.g. 54 58 2140 2144 O
, 58 59 2144 2145 O
corticosteroids 60 75 2146 2161 B-treatment
, 75 76 2161 2162 O
high 77 81 2163 2167 O
dose 82 86 2168 2172 O
estrogens 87 96 2173 2182 B-treatment
, 96 97 2182 2183 O
methotrexate 98 110 2184 2196 B-treatment
, 110 111 2196 2197 O
amiodarone 112 122 2198 2208 B-treatment
, 122 123 2208 2209 O
tamoxifen 124 133 2210 2219 B-treatment
, 133 134 2219 2220 O
valproic 135 143 2221 2229 B-treatment
acid 144 148 2230 2234 I-treatment
, 148 149 2234 2235 O
sulfasalazine 150 163 2236 2249 B-treatment
, 163 164 2249 2250 O
or 165 167 2251 2253 O
oxacillin 168 177 2254 2263 B-treatment
for 178 181 2264 2267 O
more 182 186 2268 2272 O
than 187 191 2273 2277 O
2 192 193 2278 2279 B-lower_bound
weeks 194 199 2280 2285 I-lower_bound
in 200 202 2286 2288 O
the 203 206 2289 2292 O
6 207 208 2293 2294 O
months 209 215 2295 2301 O
prior 216 221 2302 2307 O
to 222 224 2308 2310 O
the 225 228 2311 2314 O
study 229 234 2315 2320 O

Use 0 3 2321 2324 O
of 4 6 2325 2327 O
drugs 7 12 2328 2333 O
which 13 18 2334 2339 O
can 19 22 2340 2343 O
potentially 23 34 2344 2355 O
decrease 35 43 2356 2364 O
hepatic 44 51 2365 2372 B-treatment
steatosis 52 61 2373 2382 I-treatment
during 62 68 2383 2389 O
previous 69 77 2390 2398 B-upper_bound
3 78 79 2399 2400 I-upper_bound
months 80 86 2401 2407 I-upper_bound

approved 0 8 2408 2416 O
hormonal 9 17 2417 2425 B-contraception_consent
contraceptives 18 32 2426 2440 I-contraception_consent
, 32 33 2440 2441 O
such 34 38 2442 2446 O
as 39 41 2447 2449 O
birth 42 47 2450 2455 B-contraception_consent
control 48 55 2456 2463 I-contraception_consent
pills 56 61 2464 2469 I-contraception_consent
, 61 62 2469 2470 O
patch 63 68 2471 2476 B-contraception_consent
or 69 71 2477 2479 I-contraception_consent
ring 72 76 2480 2484 I-contraception_consent
; 76 77 2484 2485 O
Depo 78 82 2486 2490 B-contraception_consent
- 82 83 2490 2491 I-contraception_consent
Provera 83 90 2491 2498 I-contraception_consent
, 90 91 2498 2499 O
Implanon 92 100 2500 2508 B-contraception_consent

lactating 0 9 2509 2518 O
woman 10 15 2519 2524 B-gender

surgical 0 8 2525 2533 O
sterilization 9 22 2534 2547 O
, 22 23 2547 2548 O
such 24 28 2549 2553 O
as 29 31 2554 2556 O
hysterectomy 32 44 2557 2569 B-treatment
, 44 45 2569 2570 O
tubal 46 51 2571 2576 B-treatment
ligation 52 60 2577 2585 I-treatment
or 61 63 2586 2588 O
vasectomy 64 73 2589 2598 B-treatment

ursodeoxycholic 0 15 2599 2614 B-treatment
acid 16 20 2615 2619 I-treatment
, 20 21 2619 2620 O
thiazolidinediones 22 40 2621 2639 B-treatment
, 40 41 2639 2640 O
high 42 46 2641 2645 B-treatment
- 46 47 2645 2646 I-treatment
dose 47 51 2646 2650 I-treatment
vitamin 52 59 2651 2658 I-treatment
E 60 61 2659 2660 I-treatment
, 61 62 2660 2661 O
betaine 63 70 2662 2669 B-treatment
, 70 71 2669 2670 O
acetylcysteine 72 86 2671 2685 B-treatment
and 87 90 2686 2689 O
choline 91 98 2690 2697 B-treatment

